The global Choroideremia Treatment market was valued at US$ 3340 million in 2023 and is anticipated to reach US$ 4690.3 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.

Choroideremia Treatment Market

Choroideremia is an X-linked chorioretinal dystrophy characterized by the diffuse, progressive degeneration of the retinal pigment epithelium (RPE), photoreceptors and choriocapillaris. It is caused by a mutation in the CHM gene and is the focus of exciting basic and clinical research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Choroideremia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Choroideremia Treatment.

Report Scope

The Choroideremia Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Choroideremia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Choroideremia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Choroideremia Treatment Market Report

Report Metric	Details
Report Name	Choroideremia Treatment Market
Accounted market size in 2023	US$ 3340 million
Forecasted market size in 2030	US$ 4690.3 million
CAGR	5.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Oral Intravenous
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis AG, Spark Therapeutics, Bluebird Bio Inc., Biogen, Copernicus Therapeutics, Inc., 4D Molecular Therapeutics, Wize Pharma Inc., Retina Implant AG, Hoffmann-La Roche Ltd, Pixium Vision, Merck, Teva
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Choroideremia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Choroideremia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Choroideremia Treatment Market growing?

Ans: The Choroideremia Treatment Market witnessing a CAGR of 5.0% during the forecast period 2024-2030.

What is the Choroideremia Treatment Market size in 2030?

Ans: The Choroideremia Treatment Market size in 2030 will be US$ 4690.3 million.

Who are the main players in the Choroideremia Treatment Market report?

Ans: The main players in the Choroideremia Treatment Market are Novartis AG, Spark Therapeutics, Bluebird Bio Inc., Biogen, Copernicus Therapeutics, Inc., 4D Molecular Therapeutics, Wize Pharma Inc., Retina Implant AG, Hoffmann-La Roche Ltd, Pixium Vision, Merck, Teva

What are the Application segmentation covered in the Choroideremia Treatment Market report?

Ans: The Applications covered in the Choroideremia Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Choroideremia Treatment Market report?

Ans: The Types covered in the Choroideremia Treatment Market report are Oral, Intravenous

1 Choroideremia Treatment Market Overview

1.1 Product Overview and Scope of Choroideremia Treatment

1.2 Choroideremia Treatment Segment by Type

1.2.1 Global Choroideremia Treatment Market Value Comparison by Type (2024-2030)

1.2.2 Oral

1.2.3 Intravenous

1.3 Choroideremia Treatment Segment by Application

1.3.1 Global Choroideremia Treatment Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Choroideremia Treatment Market Size Estimates and Forecasts

1.4.1 Global Choroideremia Treatment Revenue 2019-2030

1.4.2 Global Choroideremia Treatment Sales 2019-2030

1.4.3 Global Choroideremia Treatment Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Choroideremia Treatment Market Competition by Manufacturers

2.1 Global Choroideremia Treatment Sales Market Share by Manufacturers (2019-2024)

2.2 Global Choroideremia Treatment Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Choroideremia Treatment Average Price by Manufacturers (2019-2024)

2.4 Global Choroideremia Treatment Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Choroideremia Treatment, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Choroideremia Treatment, Product Type & Application

2.7 Choroideremia Treatment Market Competitive Situation and Trends

2.7.1 Choroideremia Treatment Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Choroideremia Treatment Players Market Share by Revenue

2.7.3 Global Choroideremia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Choroideremia Treatment Retrospective Market Scenario by Region

3.1 Global Choroideremia Treatment Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Choroideremia Treatment Global Choroideremia Treatment Sales by Region: 2019-2030

3.2.1 Global Choroideremia Treatment Sales by Region: 2019-2024

3.2.2 Global Choroideremia Treatment Sales by Region: 2025-2030

3.3 Global Choroideremia Treatment Global Choroideremia Treatment Revenue by Region: 2019-2030

3.3.1 Global Choroideremia Treatment Revenue by Region: 2019-2024

3.3.2 Global Choroideremia Treatment Revenue by Region: 2025-2030

3.4 North America Choroideremia Treatment Market Facts & Figures by Country

3.4.1 North America Choroideremia Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Choroideremia Treatment Sales by Country (2019-2030)

3.4.3 North America Choroideremia Treatment Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Choroideremia Treatment Market Facts & Figures by Country

3.5.1 Europe Choroideremia Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Choroideremia Treatment Sales by Country (2019-2030)

3.5.3 Europe Choroideremia Treatment Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Choroideremia Treatment Market Facts & Figures by Country

3.6.1 Asia Pacific Choroideremia Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Choroideremia Treatment Sales by Country (2019-2030)

3.6.3 Asia Pacific Choroideremia Treatment Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Choroideremia Treatment Market Facts & Figures by Country

3.7.1 Latin America Choroideremia Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Choroideremia Treatment Sales by Country (2019-2030)

3.7.3 Latin America Choroideremia Treatment Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Choroideremia Treatment Market Facts & Figures by Country

3.8.1 Middle East and Africa Choroideremia Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Choroideremia Treatment Sales by Country (2019-2030)

3.8.3 Middle East and Africa Choroideremia Treatment Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Choroideremia Treatment Sales by Type (2019-2030)

4.1.1 Global Choroideremia Treatment Sales by Type (2019-2024)

4.1.2 Global Choroideremia Treatment Sales by Type (2025-2030)

4.1.3 Global Choroideremia Treatment Sales Market Share by Type (2019-2030)

4.2 Global Choroideremia Treatment Revenue by Type (2019-2030)

4.2.1 Global Choroideremia Treatment Revenue by Type (2019-2024)

4.2.2 Global Choroideremia Treatment Revenue by Type (2025-2030)

4.2.3 Global Choroideremia Treatment Revenue Market Share by Type (2019-2030)

4.3 Global Choroideremia Treatment Price by Type (2019-2030)

5 Segment by Application

5.1 Global Choroideremia Treatment Sales by Application (2019-2030)

5.1.1 Global Choroideremia Treatment Sales by Application (2019-2024)

5.1.2 Global Choroideremia Treatment Sales by Application (2025-2030)

5.1.3 Global Choroideremia Treatment Sales Market Share by Application (2019-2030)

5.2 Global Choroideremia Treatment Revenue by Application (2019-2030)

5.2.1 Global Choroideremia Treatment Revenue by Application (2019-2024)

5.2.2 Global Choroideremia Treatment Revenue by Application (2025-2030)

5.2.3 Global Choroideremia Treatment Revenue Market Share by Application (2019-2030)

5.3 Global Choroideremia Treatment Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novartis AG

6.1.1 Novartis AG Corporation Information

6.1.2 Novartis AG Description and Business Overview

6.1.3 Novartis AG Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novartis AG Choroideremia Treatment Product Portfolio

6.1.5 Novartis AG Recent Developments/Updates

6.2 Spark Therapeutics

6.2.1 Spark Therapeutics Corporation Information

6.2.2 Spark Therapeutics Description and Business Overview

6.2.3 Spark Therapeutics Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Spark Therapeutics Choroideremia Treatment Product Portfolio

6.2.5 Spark Therapeutics Recent Developments/Updates

6.3 Bluebird Bio Inc.

6.3.1 Bluebird Bio Inc. Corporation Information

6.3.2 Bluebird Bio Inc. Description and Business Overview

6.3.3 Bluebird Bio Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Bluebird Bio Inc. Choroideremia Treatment Product Portfolio

6.3.5 Bluebird Bio Inc. Recent Developments/Updates

6.4 Biogen

6.4.1 Biogen Corporation Information

6.4.2 Biogen Description and Business Overview

6.4.3 Biogen Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Biogen Choroideremia Treatment Product Portfolio

6.4.5 Biogen Recent Developments/Updates

6.5 Copernicus Therapeutics, Inc.

6.5.1 Copernicus Therapeutics, Inc. Corporation Information

6.5.2 Copernicus Therapeutics, Inc. Description and Business Overview

6.5.3 Copernicus Therapeutics, Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Copernicus Therapeutics, Inc. Choroideremia Treatment Product Portfolio

6.5.5 Copernicus Therapeutics, Inc. Recent Developments/Updates

6.6 4D Molecular Therapeutics

6.6.1 4D Molecular Therapeutics Corporation Information

6.6.2 4D Molecular Therapeutics Description and Business Overview

6.6.3 4D Molecular Therapeutics Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.6.4 4D Molecular Therapeutics Choroideremia Treatment Product Portfolio

6.6.5 4D Molecular Therapeutics Recent Developments/Updates

6.7 Wize Pharma Inc.

6.6.1 Wize Pharma Inc. Corporation Information

6.6.2 Wize Pharma Inc. Description and Business Overview

6.6.3 Wize Pharma Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Wize Pharma Inc. Choroideremia Treatment Product Portfolio

6.7.5 Wize Pharma Inc. Recent Developments/Updates

6.8 Retina Implant AG

6.8.1 Retina Implant AG Corporation Information

6.8.2 Retina Implant AG Description and Business Overview

6.8.3 Retina Implant AG Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Retina Implant AG Choroideremia Treatment Product Portfolio

6.8.5 Retina Implant AG Recent Developments/Updates

6.9 Hoffmann-La Roche Ltd

6.9.1 Hoffmann-La Roche Ltd Corporation Information

6.9.2 Hoffmann-La Roche Ltd Description and Business Overview

6.9.3 Hoffmann-La Roche Ltd Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Hoffmann-La Roche Ltd Choroideremia Treatment Product Portfolio

6.9.5 Hoffmann-La Roche Ltd Recent Developments/Updates

6.10 Pixium Vision

6.10.1 Pixium Vision Corporation Information

6.10.2 Pixium Vision Description and Business Overview

6.10.3 Pixium Vision Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Pixium Vision Choroideremia Treatment Product Portfolio

6.10.5 Pixium Vision Recent Developments/Updates

6.11 Merck

6.11.1 Merck Corporation Information

6.11.2 Merck Choroideremia Treatment Description and Business Overview

6.11.3 Merck Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Merck Choroideremia Treatment Product Portfolio

6.11.5 Merck Recent Developments/Updates

6.12 Teva

6.12.1 Teva Corporation Information

6.12.2 Teva Choroideremia Treatment Description and Business Overview

6.12.3 Teva Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Teva Choroideremia Treatment Product Portfolio

6.12.5 Teva Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Choroideremia Treatment Industry Chain Analysis

7.2 Choroideremia Treatment Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Choroideremia Treatment Production Mode & Process

7.4 Choroideremia Treatment Sales and Marketing

7.4.1 Choroideremia Treatment Sales Channels

7.4.2 Choroideremia Treatment Distributors

7.5 Choroideremia Treatment Customers

8 Choroideremia Treatment Market Dynamics

8.1 Choroideremia Treatment Industry Trends

8.2 Choroideremia Treatment Market Drivers

8.3 Choroideremia Treatment Market Challenges

8.4 Choroideremia Treatment Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Copernicus Therapeutics Inc

4D Molecular Therapeutics

Retina Implant AG

Hoffmann-La Roche Ltd

List of Tables

Table 1. Global Choroideremia Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Choroideremia Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Choroideremia Treatment Market Competitive Situation by Manufacturers in 2023

Table 4. Global Choroideremia Treatment Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Choroideremia Treatment Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Choroideremia Treatment Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Choroideremia Treatment Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Choroideremia Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Choroideremia Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Choroideremia Treatment, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Choroideremia Treatment, Product Type & Application

Table 12. Global Key Manufacturers of Choroideremia Treatment, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Choroideremia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroideremia Treatment as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Choroideremia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Choroideremia Treatment Sales by Region (2019-2024) & (K Units)

Table 18. Global Choroideremia Treatment Sales Market Share by Region (2019-2024)

Table 19. Global Choroideremia Treatment Sales by Region (2025-2030) & (K Units)

Table 20. Global Choroideremia Treatment Sales Market Share by Region (2025-2030)

Table 21. Global Choroideremia Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Choroideremia Treatment Revenue Market Share by Region (2019-2024)

Table 23. Global Choroideremia Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Choroideremia Treatment Revenue Market Share by Region (2025-2030)

Table 25. North America Choroideremia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Choroideremia Treatment Sales by Country (2019-2024) & (K Units)

Table 27. North America Choroideremia Treatment Sales by Country (2025-2030) & (K Units)

Table 28. North America Choroideremia Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Choroideremia Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Choroideremia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Choroideremia Treatment Sales by Country (2019-2024) & (K Units)

Table 32. Europe Choroideremia Treatment Sales by Country (2025-2030) & (K Units)

Table 33. Europe Choroideremia Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Choroideremia Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Choroideremia Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Choroideremia Treatment Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Choroideremia Treatment Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Choroideremia Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Choroideremia Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Choroideremia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Choroideremia Treatment Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Choroideremia Treatment Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Choroideremia Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Choroideremia Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Choroideremia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Choroideremia Treatment Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Choroideremia Treatment Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Choroideremia Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Choroideremia Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Choroideremia Treatment Sales (K Units) by Type (2019-2024)

Table 51. Global Choroideremia Treatment Sales (K Units) by Type (2025-2030)

Table 52. Global Choroideremia Treatment Sales Market Share by Type (2019-2024)

Table 53. Global Choroideremia Treatment Sales Market Share by Type (2025-2030)

Table 54. Global Choroideremia Treatment Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Choroideremia Treatment Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Choroideremia Treatment Revenue Market Share by Type (2019-2024)

Table 57. Global Choroideremia Treatment Revenue Market Share by Type (2025-2030)

Table 58. Global Choroideremia Treatment Price (US$/Unit) by Type (2019-2024)

Table 59. Global Choroideremia Treatment Price (US$/Unit) by Type (2025-2030)

Table 60. Global Choroideremia Treatment Sales (K Units) by Application (2019-2024)

Table 61. Global Choroideremia Treatment Sales (K Units) by Application (2025-2030)

Table 62. Global Choroideremia Treatment Sales Market Share by Application (2019-2024)

Table 63. Global Choroideremia Treatment Sales Market Share by Application (2025-2030)

Table 64. Global Choroideremia Treatment Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Choroideremia Treatment Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Choroideremia Treatment Revenue Market Share by Application (2019-2024)

Table 67. Global Choroideremia Treatment Revenue Market Share by Application (2025-2030)

Table 68. Global Choroideremia Treatment Price (US$/Unit) by Application (2019-2024)

Table 69. Global Choroideremia Treatment Price (US$/Unit) by Application (2025-2030)

Table 70. Novartis AG Corporation Information

Table 71. Novartis AG Description and Business Overview

Table 72. Novartis AG Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Novartis AG Choroideremia Treatment Product

Table 74. Novartis AG Recent Developments/Updates

Table 75. Spark Therapeutics Corporation Information

Table 76. Spark Therapeutics Description and Business Overview

Table 77. Spark Therapeutics Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Spark Therapeutics Choroideremia Treatment Product

Table 79. Spark Therapeutics Recent Developments/Updates

Table 80. Bluebird Bio Inc. Corporation Information

Table 81. Bluebird Bio Inc. Description and Business Overview

Table 82. Bluebird Bio Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Bluebird Bio Inc. Choroideremia Treatment Product

Table 84. Bluebird Bio Inc. Recent Developments/Updates

Table 85. Biogen Corporation Information

Table 86. Biogen Description and Business Overview

Table 87. Biogen Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Biogen Choroideremia Treatment Product

Table 89. Biogen Recent Developments/Updates

Table 90. Copernicus Therapeutics, Inc. Corporation Information

Table 91. Copernicus Therapeutics, Inc. Description and Business Overview

Table 92. Copernicus Therapeutics, Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Copernicus Therapeutics, Inc. Choroideremia Treatment Product

Table 94. Copernicus Therapeutics, Inc. Recent Developments/Updates

Table 95. 4D Molecular Therapeutics Corporation Information

Table 96. 4D Molecular Therapeutics Description and Business Overview

Table 97. 4D Molecular Therapeutics Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. 4D Molecular Therapeutics Choroideremia Treatment Product

Table 99. 4D Molecular Therapeutics Recent Developments/Updates

Table 100. Wize Pharma Inc. Corporation Information

Table 101. Wize Pharma Inc. Description and Business Overview

Table 102. Wize Pharma Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Wize Pharma Inc. Choroideremia Treatment Product

Table 104. Wize Pharma Inc. Recent Developments/Updates

Table 105. Retina Implant AG Corporation Information

Table 106. Retina Implant AG Description and Business Overview

Table 107. Retina Implant AG Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Retina Implant AG Choroideremia Treatment Product

Table 109. Retina Implant AG Recent Developments/Updates

Table 110. Hoffmann-La Roche Ltd Corporation Information

Table 111. Hoffmann-La Roche Ltd Description and Business Overview

Table 112. Hoffmann-La Roche Ltd Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Hoffmann-La Roche Ltd Choroideremia Treatment Product

Table 114. Hoffmann-La Roche Ltd Recent Developments/Updates

Table 115. Pixium Vision Corporation Information

Table 116. Pixium Vision Description and Business Overview

Table 117. Pixium Vision Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Pixium Vision Choroideremia Treatment Product

Table 119. Pixium Vision Recent Developments/Updates

Table 120. Merck Corporation Information

Table 121. Merck Description and Business Overview

Table 122. Merck Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Merck Choroideremia Treatment Product

Table 124. Merck Recent Developments/Updates

Table 125. Teva Corporation Information

Table 126. Teva Description and Business Overview

Table 127. Teva Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Teva Choroideremia Treatment Product

Table 129. Teva Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Choroideremia Treatment Distributors List

Table 133. Choroideremia Treatment Customers List

Table 134. Choroideremia Treatment Market Trends

Table 135. Choroideremia Treatment Market Drivers

Table 136. Choroideremia Treatment Market Challenges

Table 137. Choroideremia Treatment Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Choroideremia Treatment

Figure 2. Global Choroideremia Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Choroideremia Treatment Market Share by Type in 2023 & 2030

Figure 4. Oral Product Picture

Figure 5. Intravenous Product Picture

Figure 6. Global Choroideremia Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Choroideremia Treatment Market Share by Application in 2023 & 2030

Figure 8. Hospital Pharmacies

Figure 9. Retail Pharmacies

Figure 10. Online Pharmacies

Figure 11. Global Choroideremia Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Choroideremia Treatment Market Size (2019-2030) & (US$ Million)

Figure 13. Global Choroideremia Treatment Sales (2019-2030) & (K Units)

Figure 14. Global Choroideremia Treatment Average Price (US$/Unit) & (2019-2030)

Figure 15. Choroideremia Treatment Report Years Considered

Figure 16. Choroideremia Treatment Sales Share by Manufacturers in 2023

Figure 17. Global Choroideremia Treatment Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Choroideremia Treatment Players: Market Share by Revenue in 2023

Figure 19. Choroideremia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Choroideremia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Choroideremia Treatment Sales Market Share by Country (2019-2030)

Figure 22. North America Choroideremia Treatment Revenue Market Share by Country (2019-2030)

Figure 23. United States Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Choroideremia Treatment Sales Market Share by Country (2019-2030)

Figure 26. Europe Choroideremia Treatment Revenue Market Share by Country (2019-2030)

Figure 27. Germany Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Choroideremia Treatment Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Choroideremia Treatment Revenue Market Share by Region (2019-2030)

Figure 34. China Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Choroideremia Treatment Sales Market Share by Country (2019-2030)

Figure 42. Latin America Choroideremia Treatment Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Choroideremia Treatment Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Choroideremia Treatment Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Choroideremia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Choroideremia Treatment by Type (2019-2030)

Figure 52. Global Revenue Market Share of Choroideremia Treatment by Type (2019-2030)

Figure 53. Global Choroideremia Treatment Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Choroideremia Treatment by Application (2019-2030)

Figure 55. Global Revenue Market Share of Choroideremia Treatment by Application (2019-2030)

Figure 56. Global Choroideremia Treatment Price (US$/Unit) by Application (2019-2030)

Figure 57. Choroideremia Treatment Value Chain

Figure 58. Choroideremia Treatment Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-16W9482

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Pterygium Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-12E13833

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Pan Uveitis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-13H14182

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Children's Medical Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-17Z13188

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Choroideremia Treatment Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-37V14265

Global Choroideremia Treatment Market Research Report 2024

FEATURED COMPANIES

Choroideremia Treatment Market Size

Choroideremia Treatment Market

Report Scope

Scope of Choroideremia Treatment Market Report

Chapter Outline

FAQ for this report

How fast is Choroideremia Treatment Market growing?

What is the Choroideremia Treatment Market size in 2030?

Who are the main players in the Choroideremia Treatment Market report?

What are the Application segmentation covered in the Choroideremia Treatment Market report?

What are the Type segmentation covered in the Choroideremia Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS